Pros and cons for the development of new antiepileptic drugs.
- 1 January 2002
- journal article
- Published by Springer Nature in CNS Drugs
- Vol. 16 (5) , 285-289
- https://doi.org/10.2165/00023210-200216050-00001
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Cost Minimization Analysis of Antiepileptic Drugs in Newly Diagnosed Epilepsy in 12 European CountriesEpilepsia, 2000
- Early Identification of Refractory EpilepsyNew England Journal of Medicine, 2000
- Neurocysticercosis and epilepsy in developing countriesJournal of Neurology, Neurosurgery & Psychiatry, 2000
- The Long‐Term Use of Gabapentin, Lamotrigine, and Vigabatrin in Patients with Chronic EpilepsyEpilepsia, 1999
- Ensuring Appropriate Care in EpilepsyDisease Management and Health Outcomes, 1998
- Epidemiology of the epilepsies.Journal of Neurology, Neurosurgery & Psychiatry, 1996
- Some Aspects of Prognosis in the Epilepsies: A ReviewEpilepsia, 1993
- Do prophylactic anticonvulsant drugs alter the pattern of seizures after craniotomy?Journal of Neurology, Neurosurgery & Psychiatry, 1992
- Comprehensive primary health care antiepileptic drug treatment programme in rural and semi-urban KenyaThe Lancet, 1991
- Comparison of Carbamazepine, Phenobarbital, Phenytoin, and Primidone in Partial and Secondarily Generalized Tonic–Clonic SeizuresNew England Journal of Medicine, 1985